We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

VASTox Initiates Fifth Proprietary Drug Discovery Programme in Cancer

News   Apr 13, 2006

 
VASTox Initiates Fifth Proprietary Drug Discovery Programme in Cancer
 
 
Advertisement
 

RELATED ARTICLES

Team Synthesizes Safer Nonaddictive Analgesics

News

A team has discovered a new class of drugs, capable of relieving pain and reducing fever without the danger of addiction or damage to the liver or kidneys.

READ MORE

A Watched Pot Never Boils… But That’s Not the Case With DNA

News

Liquid droplets formed from DNA display a peculiar response to enzymes. An international collaboration has now been able to explain the mechanisms behind bubble formation.

READ MORE

Mutated Form of SARS-CoV-2 Is Dominant, But Doesn't Make Patients Sicker, Study Says

News

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE